Skip to main content
Top
Published in: Archives of Dermatological Research 5/2024

01-07-2024 | Vitiligo | Short Report

Use of complementary and alternative medicine in vitiligo: a cross-sectional survey

Authors: Sneha Poondru, Lynna J. Yang, Roopal V. Kundu

Published in: Archives of Dermatological Research | Issue 5/2024

Login to get access

Abstract

Vitiligo is characterized by skin depigmentation, which can lead to profound psychological effects and decreased quality of life, especially for those with skin of color. Individuals with vitiligo may utilize complementary and alternative medicine (CAM) due to limited treatment options with varying efficacy.
An anonymous, multiple-choice, cross-sectional questionnaire was distributed to participants with vitiligo in the United States through online forums. Data on disease characteristics, use of prescription medications, use of topical therapies, supplements, and diets, and perceptions of CAM were collected.
In total, 625 respondents completed the survey. Overall, 32.5% of participants (203/625) have tried CAM. Commonly reported CAM include supplements of vitamin D (57.7%, 116/203), vitamin B12 (46.3%, 93/203), vitamin C (27.4%, 55/203), topical Nigella sativa oil (26.4%, 53/203), oral omega-3 fatty acids (24.9%, 50/203), folic acid (22.9%, 46/203), and vitamin E (22.9%, 46/203). Frequently cited reasons for CAM use include desire to try “new” (40.4%, 82/203) or “more natural” (26.6%, 54/203) therapies, “frustration with conventional medicine” (24.6%, 50/203), and fear of “adverse side effects of conventional medicine” (23.6%, 48/203). Non-White participants were more likely than their White counterparts to report CAM use and have more positive perceptions of CAM therapies. Less than half (43.3%, 88/203) of CAM users reported that they disclosed their use of CAM with their physician.
Dermatologists should be mindful of CAM and ask patients about their use. Further investigation of the role of CAM as adjuvant therapy for vitiligo is warranted to better advise patients.
Literature
1.
go back to reference Shakhbazova A et al (2021) A Systematic Review of Nutrition, supplement, and herbal-based adjunctive therapies for Vitiligo. J Altern Complement Med 27(4):294–311CrossRefPubMed Shakhbazova A et al (2021) A Systematic Review of Nutrition, supplement, and herbal-based adjunctive therapies for Vitiligo. J Altern Complement Med 27(4):294–311CrossRefPubMed
2.
go back to reference Elzahrani M et al (2020) Perceptions, knowledge, and attitudes toward complementary and alternative medicine among Saudi patients with vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 29(4):165–168PubMed Elzahrani M et al (2020) Perceptions, knowledge, and attitudes toward complementary and alternative medicine among Saudi patients with vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 29(4):165–168PubMed
3.
go back to reference Bhalla M, Thami GP (2010) Factors predicting the preference of complementary and alternative systems of medicine in treatment of vitiligo. Indian J Dermatol Venereol Leprol 76(6):705–707CrossRefPubMed Bhalla M, Thami GP (2010) Factors predicting the preference of complementary and alternative systems of medicine in treatment of vitiligo. Indian J Dermatol Venereol Leprol 76(6):705–707CrossRefPubMed
5.
go back to reference Simpson EL, Basco M, Hanifin J (2003) A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat 14(3):144–147PubMed Simpson EL, Basco M, Hanifin J (2003) A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat 14(3):144–147PubMed
6.
go back to reference Damevska K et al (2014) Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther 27(5):281–283CrossRefPubMed Damevska K et al (2014) Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther 27(5):281–283CrossRefPubMed
7.
go back to reference Saleh HM, Abdel Fattah NS, Hamza HT (2013) Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 29(1):34–40CrossRefPubMed Saleh HM, Abdel Fattah NS, Hamza HT (2013) Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 29(1):34–40CrossRefPubMed
8.
go back to reference Karagüzel G et al (2016) Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study. Clin Nutr ESPEN 15:28–31CrossRefPubMed Karagüzel G et al (2016) Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study. Clin Nutr ESPEN 15:28–31CrossRefPubMed
9.
go back to reference Watabe A et al (2018) Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: a blinded randomized clinical trial. J Dermatol 45(4):456–462CrossRefPubMed Watabe A et al (2018) Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: a blinded randomized clinical trial. J Dermatol 45(4):456–462CrossRefPubMed
10.
go back to reference Juhlin L, Olsson MJ (1997) Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 77(6):460–462CrossRefPubMed Juhlin L, Olsson MJ (1997) Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 77(6):460–462CrossRefPubMed
11.
go back to reference Tjioe M et al (2002) Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82(5):369–372CrossRefPubMed Tjioe M et al (2002) Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82(5):369–372CrossRefPubMed
12.
go back to reference Elgoweini M, Din NNE (2009) Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol 49(7):852–855CrossRefPubMed Elgoweini M, Din NNE (2009) Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol 49(7):852–855CrossRefPubMed
13.
go back to reference Ghorbanibirgani A, Khalili A, Rokhafrooz D (2014) Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo. Iran Red Crescent Med J 16(6):e4515CrossRefPubMedPubMedCentral Ghorbanibirgani A, Khalili A, Rokhafrooz D (2014) Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo. Iran Red Crescent Med J 16(6):e4515CrossRefPubMedPubMedCentral
15.
go back to reference Calapai G et al (2014) Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 1: Achillea millefolium-Curcuma longa. Contact Dermat 71(1):1–12CrossRef Calapai G et al (2014) Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 1: Achillea millefolium-Curcuma longa. Contact Dermat 71(1):1–12CrossRef
Metadata
Title
Use of complementary and alternative medicine in vitiligo: a cross-sectional survey
Authors
Sneha Poondru
Lynna J. Yang
Roopal V. Kundu
Publication date
01-07-2024
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 5/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-02872-x

Other articles of this Issue 5/2024

Archives of Dermatological Research 5/2024 Go to the issue